A major manufacturer of insulin products and devices is headquartered in Copenhagen, Denmark with USA operations domiciled in Princeton, New Jersey. In 2003, the manufacturer moved its North American distribution from Cranbury, New Jersey to Plainfield, Indiana. The move compounded the daily expense of converting trade products to a repackaged sales sample detail since the vendor(s) remained located in central New Jersey. The company was faced with escalating transportation expenses, product exposure to inclement weather, increased cycle times, and the management of five separate vendors. Read more.